Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In Japan, Wegovy was just launched in February 2024, so its not widely available yet
2026 Mar 11;148(9):10225-10240
2) Zeposia (ozanimod) (PG234, Ver
Sources Wegovy 7.2mg Solution for Injection in Pre-Filled Pen Summary of Product Characteristics, Electronic Medicines Compendium: medicines.org.uk/emc/product/102093/smpc Wegovy 2.4mg FlexTouch Summary of Product Characteristics, Electronic Medicines Compendium: medicines.org.uk/emc/product/13803/smpc MHRA approval of the single-dose 7.2mg injection device, Novo Nordisk press release via PharmiWeb (14 April 2026): pharmiweb.com "'Triple-strength' Wegovy injection gets MHRA approval," Pharmacy Magazine: pharmacymagazine.co.uk Wegovy (semaglutide) EPAR Product Information, European Medicines Agency: ema.europa.eu STEP UP trial (NCT05646706), Once-weekly semaglutide 7.2mg in adults with obesity The Lancet Diabetes & Endocrinology: thelancet.com "STEP UP: Higher Semaglutide Doses Yield Greater Weight Loss in Obesity" (treatment policy estimand results), HCPLive: hcplive.com "Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial" (trial product estimand results), HCPLive: hcplive.com "STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs
US$ 25.07
US$ 22.71
US$ 28.14
US$ 29.25
